Product image of Mepivastesin (Mepivacaine Hydrochloride) supplied by GNH India

Mepivastesin

Active Ingredient:
Mepivacaine Hydrochloride
Origin:
EU

Mepivastesin (Mepivacaine Hydrochloride)

Mepivacaine Hydrochloride, the active ingredient in Mepivastesin, is a local anesthetic presented as a sterile solution for infiltration and perineural administration. It produces a reversible blockade of nerve impulse transmission, providing effective local anesthesia for dental procedures, minor surgical interventions, and other clinical situations requiring short‑duration numbness in adult patients.

GNH India supplies Mepivastesin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for healthcare providers.

Manufacturer / TM Owner

Pierrel S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Mepivastesin, a local anesthetic, is used to achieve temporary loss of sensation in specific tissues.
  • Dental procedures: provides local anesthesia for tooth extractions, restorations, and periodontal surgery.
  • Minor surgical procedures: enables infiltration anesthesia for skin suturing, biopsy, and minor orthopedic interventions.
  • Perineural anesthesia: allows nerve block for regional anesthesia in limb or facial nerve procedures.
  • Endodontic therapy: facilitates anesthesia for root canal treatment.
  • Oral surgery: supports anesthesia for implant placement and soft‑tissue removal.

How It Works

  • Mepivastesin contains mepivacaine hydrochloride, which reversibly binds to voltage‑gated sodium channels on neuronal membranes. By stabilizing the inactive state of these channels, it prevents sodium influx during depolarization, thereby inhibiting the generation and propagation of nerve impulses. This localized blockade results in temporary loss of sensation in the targeted area without affecting systemic neural activity.

Side Effects

Mepivastesin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Transient burning or stinging at the injection site
  • Mild dizziness or light‑headedness
  • Tinnitus (ringing in the ears)
  • Nausea or mild gastrointestinal upset

Serious or Rare Side Effects

  • Cardiac arrhythmias or conduction disturbances
  • Methemoglobinemia leading to cyanosis
  • Seizures due to central nervous system toxicity
  • Severe allergic reaction, including anaphylaxis

Precautions & Warnings

  • When using Mepivastesin, clinicians should observe the following precautions.
  • Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics.
  • Cardiovascular status: use cautiously in patients with conduction disorders or significant cardiac disease.
  • Dosage limits: adhere to the maximum recommended dose to avoid systemic toxicity.
  • Pregnancy: safety not established; weigh potential benefits against risks before use.
  • Elderly or hepatic impairment: consider reduced clearance and monitor for signs of toxicity.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Mepivastesin can interact with several drug classes; awareness of these interactions helps minimize risk.

Major Interactions (Avoid)

  • Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase cardiotoxicity.
  • Beta‑blockers: can potentiate bradycardia when combined.
  • Monoamine oxidase inhibitors (MAOIs): may enhance central nervous system toxicity.
  • General anesthetics (e.g., halothane, isoflurane): additive CNS depression may occur.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk at the injection site.
  • Opioids: may enhance sedation and respiratory depression when co‑administered.

Frequently Asked Questions

Mepivastesin is a sterile solution of mepivacaine hydrochloride used to provide local anesthesia for dental procedures, minor surgeries, and perineural nerve blocks. It creates a temporary, reversible loss of sensation in the targeted area, allowing clinicians to perform interventions without pain.

Mepivacaine hydrochloride blocks voltage‑gated sodium channels on nerve membranes, stabilizing them in an inactive state. This prevents sodium influx during depolarization, halting the propagation of nerve impulses and resulting in localized numbness at the site of administration.

The appropriate dose of Mepivastesin is determined by the prescribing healthcare professional based on the procedure, patient weight, and clinical context. Dosage should always follow the prescriber's instructions and the product’s labeling to ensure safety and effectiveness.

Safety data for mepivacaine hydrochloride in pregnancy and lactation are limited. Use only if the potential benefit justifies any potential risk to the fetus or infant, and discuss with a qualified healthcare provider before administration.

To order Mepivastesin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and import documentation.

Mepivastesin (mepivacaine) is an amide‑type local anesthetic with a rapid onset and intermediate duration of action, similar to lidocaine but with slightly longer analgesia and less vasodilatory effect. It is often chosen when a moderate duration of numbness is desired without the need for vasoconstrictors.

Mepivastesin should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from light and moisture, and avoid freezing. Inspect the vial for particulate matter before use.

Mepivastesin is administered by infiltration or perineural injection using a sterile syringe and appropriate needle. The clinician injects the solution directly into the tissue or around the target nerve under aseptic conditions, following standard local‑anesthetic techniques.

Serious risks include cardiovascular toxicity such as arrhythmias, central nervous system toxicity leading to seizures, methemoglobinemia, and severe allergic reactions including anaphylaxis. Prompt recognition and supportive management are essential if these events occur.

Mepivastesin should be avoided in patients with known hypersensitivity to mepivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, or individuals with uncontrolled epilepsy. Caution is also advised in patients with significant hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mepivacaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT